Vol 13, No 2 (February 29, 2024): Translational Lung Cancer Research

Original Article

“We need to work towards it, whatever it takes.”—participation factors in the acceptability and feasibility of lung cancer screening in Australia: the perspectives of key stakeholders
Rachael Helen Dodd, Ashleigh Rebecca Sharman, Mei Ling Yap, Emily Stone, Henry Marshall, Joel Rhee, Sue McCullough, Nicole Marion Rankin
The presence of micropapillary and/or solid subtypes is an independent prognostic factor for patients undergoing curative resection for stage I lung adenocarcinoma with ground-glass opacity
Runze Li, Zhifei Li, Zhenlin Yang, Bin Qiu, Fengwei Tan, Qi Xue, Shugeng Gao, Jie He
Intracranial response pattern, tolerability and biomarkers associated with brain metastases in non-small cell lung cancer treated by tislelizumab plus chemotherapy
Shen Zhao, Wei Jiang, Nong Yang, Li Liu, Yan Yu, Qiming Wang, Yuanyuan Zhao, Yunpeng Yang, Shuxiang Ma, Qitao Yu, Li Zhang, Yan Huang
Predicting disease recurrence in limited disease small cell lung cancer using cell-free DNA-based mutation and fragmentome analyses
Sehhoon Park, Jun-Kyu Kang, Naeun Lee, Se-Hoon Lee, Hwang-Phill Kim, Su Yeon Kim, Tae-You Kim, Hyemin Kim, Hyun Ae Jung, Jong-Mu Sun, Jin Seok Ahn, Myung-Ju Ahn, Keunchil Park
Systemic immune index predicts tumor-infiltrating lymphocyte intensity and immunotherapy response in small cell lung cancer
Chaoqiang Deng, Jiatao Liao, Zichen Fu, Fangqiu Fu, Di Li, Yuan Li, Jialei Wang, Haiquan Chen, Yang Zhang
Does dose reduction of afatinib affect treatment outcomes of patients with EGFR-mutant metastatic non-small cell lung cancer in real-world clinical practice?
Mau Ern Poh, Chee Shee Chai, Chong Kin Liam, Gwo Fuang Ho, Yong Kek Pang, Harissa Husainy Hasbullah, Lye Mun Tho, Ibtisam Muhamad Nor, Kean Fatt Ho, Muthukkumaran Thiagarajan, Azlina Samsudin, Azza Omar, Choo Khoon Ong, Sing Yang Soon, Sin Nee Tan, Soon Hin How
HER3 overexpression: a predictive marker for poor prognosis in advanced ALK-positive non-small cell lung cancer treated with ALK inhibitors
Meejeong Kim, Hyun-min Ju, Ji-young Song, Josephina Sampson, Richard Bayliss, Jene Choi
Outcomes following minimally invasive approaches vs. open extended lobectomy for non-small cell lung cancer: a propensity-matched analysis of the National Cancer Database
Tangbing Chen, Ernest G. Chan, Binhao Huang, Luca Bertolaccini, Hiran C. Fernando, Panagiotis T. Tasoudis, Natalia Motas, Arjun Pennathur, Wentao Fang, Jie Zhang
PD-L1 mRNA derived from tumor-educated platelets as a potential immunotherapy biomarker in non-small cell lung cancer
Zhihuang Hu, Na Wang, Yao Zhang, Daoyun Zhang, Si Sun, Hui Yu, Ying Lin, Xinmin Zhao, Huijie Wang, Xianghua Wu, Yoshinobu Ichiki, Satoshi Watanabe, Ziying Gong, Jianhua Chang, Jialei Wang

Brief Report

Fibre-based fluorescence-lifetime imaging microscopy: a real-time biopsy guidance tool for suspected lung cancer
Susan Fernandes, Elvira Williams, Neil Finlayson, Hazel Stewart, Catharine Dhaliwal, David A. Dorward, William A. Wallace, Ahsan R. Akram, James Stone, Kevin Dhaliwal, Gareth O. S. Williams